Top compounds associated with response to RILPL2


Feature Type Standardized
Nominal ANOVA
mRNA ATRA CTRPv2 pan-cancer AAC 0.29 1e-13
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.28 5e-13
mRNA YK 4-279 GDSC1000 pan-cancer AAC 0.26 6e-10
mRNA Bleomycin GDSC1000 pan-cancer AAC 0.21 3e-07
mRNA Gemcitabine gCSI pan-cancer AAC 0.27 1e-06
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA TKI258 CCLE pan-cancer AAC 0.24 2e-06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA RAF265 CCLE pan-cancer AAC 0.24 5e-06
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.17 6e-06
Download CSV